此乃要件 請即處理 閣下如 對本通函任何方面或應採取的行動 有任何疑問，應諮詢 閣下的持牌證券 交易商或註冊證券機構、銀行經理、律師、專業會計師或其他專業顧問。 閣下如已將名下之上海康耐特光學科技集團股份有限公司股份全部售出或轉讓， 應立即將本通函及隨附的代表委任表格交予買主或承讓人，或經手買賣或轉讓的 銀行、持牌證券交易商或註冊證券機構或其他代理商，以便轉交買主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本通函全部 或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Shanghai Conant Optical Co., Ltd. 上海康耐特光學科技集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2276） (1)建議派付截至2025年6月30日 止 六個月之中期股息； (2)發行股份的一般授權； 及 (3)2025年第三次臨時股東大會通告 上海康耐特光學科技集團股份有限公司謹訂於2025年9月9日（星 期 二）上 午 十 時 正 假座中國上海市浦東新區川大路555號 ...

Core Viewpoint - The company reported its 2025H1 performance, which met expectations, with significant growth in revenue and net profit driven by high-value products and automation upgrades [1][2]. Financial Performance - 2025H1 revenue reached 1.084 billion yuan, a year-on-year increase of 11.0% - The number of units sold was 93.1 million, up 7.5% year-on-year - Gross profit was 444 million yuan, reflecting a 16.2% increase year-on-year, with a gross margin of 41.0%, up 1.8 percentage points - Net profit attributable to shareholders was 273 million yuan, a 30.7% year-on-year increase, with a net profit margin of 25.2%, up 3.8 percentage points - The company declared an interim dividend of 0.15 yuan per share, corresponding to a payout ratio of 26.4% [1][2]. Product Structure and Market Focus - The product revenue breakdown for 2025H1 showed standard lenses at 513 million yuan (+20.0%), functional lenses at 382 million yuan (+8.8%), and customized lenses at 185 million yuan (-4.9%) - The gross margins for standard, functional, and customized lenses were 33.6%, 40.6%, and 61.9%, respectively, with improvements of 2.8, 2.8, and 2.4 percentage points year-on-year [2]. - Revenue by region for 2025H1 was as follows: Mainland China 359 million yuan (+19.0%), Asia (excluding Mainland China) 295 million yuan (+22.5%), Americas 220 million yuan (-1.8%), Europe 171 million yuan (+6.0%), Oceania 26 million yuan (-30.5%), and Africa 13 million yuan (+22.1%) [2]. Manufacturing and Supply Chain - The company has strong manufacturing capabilities and is focusing on enhancing its own brand and domestic market presence - It has over 700,000 SKUs and emphasizes product research and development, with a significant client base including high-end brands [3]. - The company is expanding its global production capacity, with new production lines set to launch in Japan and Thailand, enhancing its supply chain advantages [3]. XR Business Development - The XR business, including AR and AI glasses, is expanding both domestically and internationally, with increasing collaboration with technology and consumer electronics companies - The partnership with GoerTek, which has increased its stake to 20%, is expected to enhance strategic cooperation and business opportunities [4]. - The market for smart glasses is growing rapidly, with significant sales increases noted for products like the Ray-Ban Meta [4]. Long-term Growth Potential - Smart glasses are positioned to replace various traditional devices, with significant market potential - The demand for traditional eyewear is also expected to grow, with a shift towards higher-value, functional products [5]. - The company is well-positioned to benefit from the increasing demand for smart eyewear, which is expected to drive both volume and price growth in the industry [5]. Equity Incentive Plan - The company has adjusted its equity incentive plan, extending the assessment period and maintaining the grant price and number of shares - This move reflects the company's confidence in long-term growth and aims to align the interests of management and employees [6][7].

Industry Overview - The lens industry in China is expected to maintain a good growth momentum due to rigid demand, scenario refinement, and structural optimization, with a projected CAGR of 6.00% for manufacturer sales and 5.04% for retail sales from 2019 to 2024, reaching sales of 29.75 billion and 53.71 billion yuan by 2029 respectively [1] Company Strategy - The company has a flexible strategy across the industry chain, enhancing competitiveness and market share through deep partnerships with core suppliers like Mitsui Chemicals, which has provided a comprehensive product matrix for nearly 15 years [2] - The company ranks among the top in market share, with new production capacities in Thailand and Japan, and an increasing proportion of high unit price and high gross margin products, which is expected to further boost competitiveness and market share [2] - The company employs a C2M business model to engage directly with consumers, utilizing diversified channels to shorten the path to individual end customers, thereby enhancing profitability [2] Smart Glasses Development - The company is actively developing a second growth curve through smart glasses, with demand for lenses in AI and AR glasses, although AR glasses face technological limitations and have not yet achieved significant sales [3] - The company collaborates with leading tech and consumer electronics firms to develop customized lenses for XR products and has acquired land in Thailand for building a production base for XR product lenses [3] - The company forecasts revenues of 2.328 billion, 2.657 billion, and 2.963 billion yuan for 2025-2027, with net profits of 561 million, 672 million, and 777 million yuan respectively, driven by lens demand growth and strategic partnerships in the smart glasses sector [3]

Investment Rating - The report gives a "Buy" rating for the company, indicating a positive outlook for investment [4]. Core Views - The report highlights the company's strong position in the optical lens industry, driven by rigid demand, refined application scenarios, and structural optimization, which are expected to sustain good growth in market size [1][36]. - The company is strategically positioned across various segments of the industry chain, enhancing its competitiveness and market share [2][61]. - The company is actively developing its XR business, which is anticipated to create a second growth curve, particularly in the smart glasses segment [3][19]. Summary by Sections Company Overview - The company has been a leader in the lens manufacturing industry since its establishment in 1996, focusing on standardized lens production and expanding into customized lenses through acquisitions and partnerships [16]. Lens Industry Dynamics - The Chinese optical lens market is projected to grow, with manufacturer sales expected to reach CNY 297.5 billion and retail sales to CNY 537.1 billion by 2029, driven by increasing consumer spending and diverse vision correction needs [1][38]. - The demand for lenses is supported by rising vision problems among youth and the aging population, leading to a stable demand for corrective lenses [44][47]. Competitive Strategy - The company has established strong ties with upstream suppliers, particularly Mitsui Chemicals, ensuring a competitive advantage in raw material procurement [2][63]. - The company ranks first in domestic market share by sales volume and third by sales revenue, indicating a strong competitive position in a fragmented market [74][76]. Financial Projections - Revenue forecasts for 2025-2027 are CNY 23.28 billion, CNY 26.57 billion, and CNY 29.63 billion, with net profits projected at CNY 5.61 billion, CNY 6.72 billion, and CNY 7.77 billion respectively, reflecting robust growth driven by traditional and smart lens segments [4][5].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the market benchmark [8]. Core Insights - The company reported a solid performance in H1 2025, with revenue reaching 1.084 billion RMB, a year-on-year growth of 11.0%. The net profit attributable to shareholders was 273 million RMB, reflecting a 30.7% increase year-on-year [7]. - The company is focusing on optimizing its product structure and enhancing its domestic market presence, with significant growth in standard lens products and a strong emphasis on high-value products [7][8]. - The XR (Extended Reality) business is expanding successfully, with strategic partnerships enhancing growth opportunities, particularly in the smart glasses segment [8]. Financial Data and Profit Forecast - Revenue projections for the company are as follows: 2023: 1.76 billion RMB, 2024: 2.061 billion RMB, 2025E: 2.403 billion RMB, 2026E: 2.786 billion RMB, and 2027E: 3.233 billion RMB, with growth rates of 13%, 17%, 17%, 16%, and 16% respectively [6]. - The net profit attributable to shareholders is forecasted to be 327 million RMB in 2023, increasing to 840 million RMB by 2027, with corresponding growth rates of 32%, 31%, 29%, 24%, and 23% [6]. - Earnings per share (EPS) are projected to grow from 0.77 RMB in 2023 to 1.75 RMB in 2027, reflecting the company's improving profitability [6]. Market Position and Competitive Advantage - The company is recognized as a leading manufacturer in the lens industry, with a comprehensive product SKU matrix and strong upstream and downstream partnerships [8]. - The company is actively enhancing its domestic market and proprietary brand initiatives, which are expected to drive new growth momentum [8]. - The smart glasses market is experiencing rapid growth, with the company positioned to leverage its first-mover advantage and strategic collaborations to expand its market share [8].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a strong performance relative to the market [7][18]. Core Insights - The company's H1 2025 performance met expectations, with revenue of 1.084 billion RMB, a year-on-year increase of 11.0%, and a net profit of 273 million RMB, reflecting a growth of 30.7% [7]. - The product structure continues to optimize, with a focus on the domestic market, and the company is enhancing its manufacturing capabilities and brand presence [7][8]. - The XR business, including AR and AI glasses, is expanding successfully, with strategic partnerships expected to yield further growth opportunities [7][8]. Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: 1,760 million RMB - 2024: 2,061 million RMB - 2025E: 2,403 million RMB - 2026E: 2,786 million RMB - 2027E: 3,233 million RMB - The expected growth rates for revenue are 13% in 2023, 17% in 2024 and 2025, and 16% in 2026 and 2027 [6][9]. - Net profit forecasts are: - 2023: 327 million RMB - 2024: 428 million RMB - 2025E: 550 million RMB - 2026E: 682 million RMB - 2027E: 840 million RMB - The expected growth rates for net profit are 32% in 2023, 31% in 2024, 29% in 2025, 24% in 2026, and 23% in 2027 [6][9]. Market Position and Competitive Advantage - The company is a leading manufacturer in the lens sector, with a comprehensive product SKU matrix and strong upstream and downstream partnerships [8]. - The company is focusing on domestic market expansion and brand development, which is expected to drive new growth momentum [8]. - The strategic investment from GoerTek, which now holds a 20% stake in the company, is anticipated to enhance collaboration and business development opportunities [7][8].

Core Viewpoint - CICC initiates coverage on Conant Optical (02276) with an "outperform" rating and a target price of HKD 54.00, based on a P/E valuation method corresponding to a 35x P/E for 2026, with expected EPS of 1.14 and 1.42 for 2025 and 2026 respectively, indicating a CAGR of 26% from 2024 to 2026 [1] Group 1: Industry Growth and Market Potential - Traditional lens market is expected to grow steadily, with Frost & Sullivan projecting global lens sales to reach approximately USD 8.2 billion by 2029, with a CAGR of 5.8% from 2024 to 2029. China is the largest lens producer globally, accounting for 26% of global exports in 2024, with the company being the second-largest resin lens seller worldwide [2] - The AI glasses market is experiencing rapid expansion, with Wellsenn forecasting global sales to exceed 10 million units for the first time in 2026, and Frost & Sullivan predicting sales to surpass RMB 100 billion by 2029. Major tech companies are launching products and investing in R&D, establishing a clear first-mover advantage [2] Group 2: Strategic Partnerships and Supply Chain - The company has a deep partnership with Mitsui Chemicals, ensuring stable customer collaboration. The availability of raw materials is relatively stable, with high-index lens materials being monopolized by Mitsui. The company is the longest-standing domestic partner of Mitsui, offering a comprehensive product range [3] - The company employs a C2M model with a flexible production line capable of handling 7 million SKUs, achieving delivery within 2-3 days, which reduces intermediaries and improves inventory turnover and response speed compared to traditional multi-layer distribution [3] - The company has long-term contracts with global leaders like Luxottica and Essilor, resulting in high order stickiness. Additionally, the company is accelerating penetration into the domestic market through its own brand, which has become a major source of revenue growth [3] Group 3: Brand Development and Technological Advancements - The company's own brand is steadily growing, with its revenue share increasing annually and gross margins higher than ODM business, contributing to overall profit improvement [4] - The company is leveraging integrated bonding technology to establish a technological barrier in the smart glasses sector, having collaborated with leading North American clients for development and small-scale orders. Multiple tech companies are simultaneously advancing AR glasses, positioning the company to benefit from industry expansion [4] - The company continues to expand its product line for functional and customized lenses, with such revenue expected to account for over half of total revenue by 2024, maintaining double-digit growth. The youth myopia lens market is concentrated among a few brands, and the company is launching various new specifications while expanding its grassroots hospital collaboration network, with expectations for gradual market share increase [4] Group 4: Market Perception and Catalysts - The company is perceived to be undervalued in terms of its technological barriers in the resin lens sector, with expectations that its market share and product rollout pace in the smart glasses field will exceed market forecasts [5] - Potential catalysts include the expansion of its own brand and the ramp-up of AI glasses production [5]

Core Viewpoint - CICC initiates coverage on Conant Optical (02276) with an "outperform" rating and a target price of HKD 54.00, based on a P/E valuation method corresponding to a 35x P/E for 2026, with expected EPS of 1.14 and 1.42 for 2025 and 2026 respectively, indicating a CAGR of 26% from 2024 to 2026 [1] Industry Overview - Traditional lens market is expected to grow steadily, with Frost & Sullivan projecting global lens sales to reach approximately USD 8.2 billion by 2029, with a CAGR of 5.8% from 2024 to 2029. China is the largest lens producer globally, accounting for 26% of global exports in 2024, with the company being the second-largest in resin lens sales [2] - The AI glasses market is experiencing rapid expansion, with Wellsenn forecasting global sales to exceed 10 million units for the first time in 2026, and Frost & Sullivan predicting sales to surpass RMB 100 billion by 2029. Major tech companies are launching products and investing in R&D, establishing a clear first-mover advantage [2] Company Strengths - Strong partnership with Mitsui Chemicals ensures stable customer collaboration, with the company being the longest domestic partner of Mitsui and having the most comprehensive product range. The availability of raw materials is relatively stable, and the company employs a C2M model with flexible production lines allowing for 2-3 day delivery, enhancing inventory turnover and response speed compared to traditional distribution [3] - The company is steadily building its own brand, with revenue contribution increasing year by year and gross margins higher than ODM business, improving overall profitability. The company has developed integrated bonding technology for smart glasses, collaborating with leading North American clients and receiving R&D and small trial orders, positioning itself to benefit from industry growth [4] - The company continues to expand its product line for functional and customized lenses, with such revenue accounting for over half of total revenue in 2024, maintaining double-digit growth. The youth defocus lens market is becoming increasingly concentrated, and the company is launching multiple new specifications while expanding its grassroots hospital cooperation network, with market share expected to gradually increase [4] Market Perception - The firm believes the market underestimates the company's technological barriers in the resin lens sector and anticipates that the company's market share and product rollout pace in the smart glasses sector will exceed expectations. Potential catalysts include the expansion of its own brand and the ramp-up of AI glasses [5]

Group 1 - The overall industry sentiment shows an upward trend in sectors such as steel, electric equipment, electronics, food and beverage, environmental protection, and retail, while sectors like oil and petrochemicals, machinery, light manufacturing, home appliances, automotive, banking, real estate, and public utilities are experiencing a downward trend [3][22] - As of August 10, 2025, notable industry data includes: automotive semi-steel tire operating rate at 74.35%, down 0.1% month-on-month; machinery equipment price index at 125.17 points, down 0.11% month-on-month; electric equipment Topcon component price at 0.7 yuan/watt, up 4.2% month-on-month; transportation with Suzhou subway passenger volume at 2.156 million, up 27.57% month-on-month; light manufacturing white cardboard price at 4010 yuan/ton, down 2.43% month-on-month [3][23][24] Group 2 - Insurance capital is increasingly allocating to equity, with banks and high-dividend sectors being core beneficiaries. By the end of Q1 2025, life and property insurance companies had invested a total of 2.82 trillion yuan in the stock market, a year-on-year increase of 44.5% [5] - The potential for insurance capital to increase its allocation to bank stocks remains significant, with estimated incremental funds of 140.4 billion yuan and 73.7 billion yuan for bank stocks in 2025, assuming 25% of new premium income is directed to the A-share market [5] Group 3 - The report on Shiyao Group indicates a revenue of 7.015 billion yuan in Q1 2025, a year-on-year decrease of 21.9%, with a net profit of 1.495 billion yuan, down 8.3%. The decrease in revenue is primarily due to the impact of price adjustments and centralized procurement policies [8][28] - The core pipeline SYS6010 (EGFRADC) shows strong potential for authorization, having started its first phase III clinical trial in March 2025, targeting patients with EGFR mutation non-small cell lung cancer [8][28] Group 4 - Shenzhen Airport's operational data shows a significant recovery, with 221,000 aircraft movements in the first half of 2025, a year-on-year increase of 7.2%, and a passenger throughput of 32.57 million, up 10.9% year-on-year [19][30] - The airport's non-aeronautical business is diversifying, with advertising revenue expected to increase as passenger traffic grows, and the new cargo station is anticipated to boost international cargo volume [19][31] Group 5 - Beiding Co. reported a revenue of 430 million yuan in the first half of 2025, a year-on-year increase of 34%, with a net profit of 56 million yuan, up 75% year-on-year. The company benefited significantly from domestic subsidies and the "old-for-new" replacement policy [10][36] - The company's gross margin improved to 49.7% in the first half of 2025, driven by high-margin products, with a notable increase in sales from new product lines [10][36]

Core Viewpoint - The company reported strong mid-year performance for 2025, with significant revenue and profit growth driven by both domestic and international business expansion, as well as product upgrades in high-value segments [1][2]. Financial Performance - For the first half of 2025, the company achieved revenue of 1.08 billion, an increase of 11.1% year-on-year; net profit attributable to shareholders was 270 million, up 30.7% [1]. - The gross margin for H1 2025 was 41.0%, an increase of 1.8 percentage points, while the net profit margin was 25.2%, up 3.8 percentage points [1]. - Product-wise, standard lens revenue was 510 million, up 20%, with a gross margin of 33.6%; functional lens revenue was 380 million, up 8.8%, with a gross margin of 40.6%; customized lens revenue was 180 million, down 4.9%, with a gross margin of 61.9% [1]. Product and Sales Growth - The company sold 9.3 million units in H1 2025, a 7.5% increase, with an average product price of 23.3 yuan, up 3.3% [1]. - The growth in standard and functional lens revenue was attributed to the promotion of high-refractive and multifunctional lenses, leading to continuous product structure upgrades [1]. Regional Performance - Domestic revenue reached 360 million, a 19.0% increase, while overseas revenue was 730 million, up 7.5% [2]. - In Asia, revenue was 300 million, up 23%; in Europe, it was 170 million, up 6%; in the Americas, it was 220 million, down 2% [2]. - The company is expanding overseas production capacity, with a customized production line in Japan expected to start in H2 2025 and a new production base in Thailand also set to begin construction in H2 2025 [2]. XR Business Development - The company is making progress in its XR business, including AR and AI glasses, with ongoing collaborations with both domestic and international technology and consumer electronics companies [2]. - The number of overseas projects is increasing, with a shift in focus from product functionality and technical validation to scaling production [2]. Profit Forecast - The company maintains its profit forecast, expecting net profits of 560 million, 670 million, and 790 million for 2025-2027, corresponding to PE ratios of 35X, 29X, and 25X [3].